How mNGS Testing Delivers Unmatched Pathogen Detection in Infectious Diseases
Delve Bio found that mNGS identified more pathogens from cerebrospinal fluid samples than all conventional diagnostic methods combined.
Read MorePosted by Andy Lundin | Nov 21, 2024 | Molecular Diagnostics |
Delve Bio found that mNGS identified more pathogens from cerebrospinal fluid samples than all conventional diagnostic methods combined.
Read MorePosted by Andy Lundin | Nov 21, 2024 | Lung Cancer, Molecular Diagnostics |
Biofidelity’s test delivers comprehensive genomic profiling for NSCLC patients from tissue or liquid biopsy samples within two days.
Read MorePosted by Andy Lundin | Nov 19, 2024 | Dementias & Alzheimer’s |
A new capillary blood test offers a simple, mail-in method to detect Alzheimer’s biomarkers, paving the way for accessible global testing.
Read MorePosted by Chris Wolski | Nov 18, 2024 | Molecular Diagnostics |
Azenta, Inc. has launched a long-read whole genome sequencing test for clinical use, offering accuracy in detecting genetic variants.
Read MorePosted by Chris Wolski | Nov 18, 2024 | Lung Cancer |
Researchers have developed a novel testing strategy for mesothelioma cancer, focusing on detecting chromosomal rearrangements in cancer DNA.
Read More